Skip to main content

Advertisement

Table 3 Number and percentage of CIN2+ cases based on the biopsies according to cytology result and previous radiotherapy status read manually

From: Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study

Cytology result No previous radiotherapy Previous radiotherapy PR 95% CI (PR)
N (%) N (%)
ASCUS + ASCH + AGC 34 (40.5) 6 (33.3) 0.8 0.4 – 1.7
LSIL 20 (37.0) 1 (25.0) 0.7 0.1 – 3.8
HSIL or worse 77 (74.8) 9 (60.0) 0.8 0.5 – 1.2
  1. PR = prevalence ratio (ratio of cytology abnormalities between the groups who did or did not receive previous radiotherapy).
  2. 95% CI = 95% confidence interval.